Innovating for a healthier future

We are discovering new therapeutics with rare & novel cannabinoids

FloraWorks

Advancing Cannabinoid Research for a New Generation of Therapeutics

After decades of restriction, cannabinoids have emerged as a frontier of discovery - interacting with the Endocannabinoid system, an abundant GPCR network; these neuromodulating small molecules can transform human health and wellness.

Merging rational-based drug design with artificial intelligence, FloraWorks' discovery platform Paragon™ will accelerate our understanding of cannabinoids and their physiological responses, leading to actionable nutraceuticals and new drug target identification.

Introducing TruCBN™

The first and only clinically validated cannabinoid to improve sleep

Learn how you can leverage clinically backed claims to transform your brand into a market frontrunner and disrupt the OTC sleep aid market!

Making Headlines

TruCBN™ in the news

Explore how TruCBN™ is redefining sleep wellness with clinically validated research, making headlines as the trusted, scientifically-backed choice for better rest.

Purchase minor cannabinoids

As the leader in minor cannabinoid supply and scientific research, we offer a diverse range of high-quality cannabinoids to meet the needs of a rapidly evolving industry. Explore our selection, including TruCBN™

Together, We Innovate

The frontier of opportunity

We believe in the power of collaboration. At FloraWorks, we accelerate positive health impacts by coming together with academia and institutions worldwide.

Join us at the frontier of discovery to unlock a deeper understanding of the endocannabinoid system and the impact cannabinoids and cannabinoid-inspired compounds can have on improving the lives of millions.

Newsroom

FloraWorks news and events

FloraWorks Welcomes Dr. Matthew Roberts as New Chief Operating Officer

FloraWorks is excited to welcome Dr. Matthew Roberts as the new Chief Operating Officer (COO). Dr. Roberts will oversee operations, supply chain management, production, quality assurance, and regulatory affairs.

TruCBN™ Study to Be Unveiled at Prestigious Sleep Conference

In a groundbreaking development, the revolutionary TruCBN™ study will be presented at the prestigious SLEEP meeting, the premier annual meeting for sleep medicine and research professionals.

Discovering the Fountain of Youth for Brain Cells: A Groundbreaking Study by FloraWorks and The Salk Institute

In an unprecedented collaborative effort, FloraWorks and The Salk Institute have unveiled groundbreaking research elucidating the neuroprotective effects of cannabinoids on aging neuronal cells.

Stay ahead in the world of cannabinoid science

Join our exclusive email list for the latest insights and breakthroughs.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.